proceeded by nucleophilic substitution with phenol 119 to deliver intermediate B by using an interrupted PummererOn the other hand, not all therapies with inhibitors and inducers with the P-450 program gave the expected ends in this review. A single possible clarification for these discrepancies might be the differential effects on different P-450